DiFusion Technologies Releases New Case Series Data on Device Poised to Revolutionize Spinal Surgeries
AUSTIN, Texas, Oct. 4, 2023 /PRNewswire/ -- DiFusion Technologies, an industry leader in advanced biomaterials for surgical implants, announced today the results of a recent case series noting the benefits of the company's proprietary ZFUZE™ technology. ZFUZE is the first FDA-cleared advanced biomaterial for spinal implants that is proven to create a highly favorable cellular and immunologic response post-surgery. Among a number of impressive findings, the case series showed ZFUZE offers: